Richard H. Brudnick's most recent trade in Scholar Rock Holding Corp was a trade of 4,675 Common Stock done at an average price of $29.6 . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Scholar Rock Holding Corp | Richard H. Brudnick | Director | Sale of securities on an exchange or to another person at price $ 29.63 per share. | 29 May 2025 | 4,675 | 16,457 (0%) | 0% | 29.6 | 138,526 | Common Stock |
| Scholar Rock Holding Corp | Richard H. Brudnick | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 29 May 2025 | 1,400 | 15,057 (0%) | 0% | 30.0 | 42,004 | Common Stock |
| Scholar Rock Holding Corp | Richard H. Brudnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 9,206 | 9,206 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Richard H. Brudnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 7,632 | 21,132 (0%) | 0% | 0 | Common Stock | |
| Prime Medicine Inc | Richard H. Brudnick | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.19 per share. | 20 May 2025 | 20,000 | 20,000 | - | 1.2 | 23,790 | Common Stock |
| Prime Medicine Inc | Richard H. Brudnick | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 225,000 | 225,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Richard H. Brudnick | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 19,300 | 57,900 | - | - | Stock Option (right to buy) | |
| Scholar Rock Holding Corp | Richard H. Brudnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Richard H. Brudnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 13,500 | 13,500 (0%) | 0% | 0 | Common Stock | |
| Prime Medicine Inc | Richard H. Brudnick | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 19,300 | 38,600 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Brudnick H. Richard | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 135,747 | 135,747 | - | - | Stock Option (right to buy) | |
| Scholar Rock Holding Corp | Richard H. Brudnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 56,000 | 56,000 | - | - | Stock Option (Right to Buy) | |
| Prime Medicine Inc | Richard H. Brudnick | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 135,747 | 135,747 | - | - | Stock Option (right to buy) |